File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial

TitleZoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial
Authors
Issue Date2009
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.obgynsurvey.com
Citation
Obstetrical And Gynecological Survey, 2009, v. 64 n. 8, p. 521-523 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/163288
ISSN
2015 Impact Factor: 1.435
2015 SCImago Journal Rankings: 1.118

 

DC FieldValueLanguage
dc.contributor.authorReid, DMen_US
dc.contributor.authorDevogelaer, JPen_US
dc.contributor.authorSaag, Ken_US
dc.contributor.authorRoux, Cen_US
dc.contributor.authorLau, CSen_US
dc.contributor.authorReginster, JYen_US
dc.contributor.authorPapanastasiou, Pen_US
dc.contributor.authorFerreira, Aen_US
dc.contributor.authorHartl, Fen_US
dc.contributor.authorFashola, Ten_US
dc.contributor.authorMesenbrink, Pen_US
dc.contributor.authorSambrook, PNen_US
dc.date.accessioned2012-09-05T05:29:39Z-
dc.date.available2012-09-05T05:29:39Z-
dc.date.issued2009en_US
dc.identifier.citationObstetrical And Gynecological Survey, 2009, v. 64 n. 8, p. 521-523en_US
dc.identifier.issn0029-7828en_US
dc.identifier.urihttp://hdl.handle.net/10722/163288-
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.obgynsurvey.comen_US
dc.relation.ispartofObstetrical and Gynecological Surveyen_US
dc.titleZoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trialen_US
dc.typeArticleen_US
dc.identifier.emailLau, CS:cslau@hku.hken_US
dc.identifier.authorityLau, CS=rp01348en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1097/01.ogx.0000356937.03800.0fen_US
dc.identifier.scopuseid_2-s2.0-73449083045en_US
dc.identifier.volume64en_US
dc.identifier.issue8en_US
dc.identifier.spage521en_US
dc.identifier.epage523en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridReid, DM=35372429900en_US
dc.identifier.scopusauthoridDevogelaer, JP=35271465400en_US
dc.identifier.scopusauthoridSaag, K=35448182000en_US
dc.identifier.scopusauthoridRoux, C=14054986200en_US
dc.identifier.scopusauthoridLau, CS=14035682100en_US
dc.identifier.scopusauthoridReginster, JY=35378176800en_US
dc.identifier.scopusauthoridPapanastasiou, P=36874895000en_US
dc.identifier.scopusauthoridFerreira, A=35733801300en_US
dc.identifier.scopusauthoridHartl, F=7102931080en_US
dc.identifier.scopusauthoridFashola, T=6603044331en_US
dc.identifier.scopusauthoridMesenbrink, P=7801593186en_US
dc.identifier.scopusauthoridSambrook, PN=7103142193en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats